Wessells N K, Spooner B S, Ash J F, Bradley M O, Luduena M A, Taylor E L, Wrenn J T, Yamada K
Science. 1971 Jan 15;171(3967):135-43. doi: 10.1126/science.171.3967.135.
In our opinion, all of the phenomena that are inhibited by cytochalasin can be thought of as resulting from contractile activity of cellular organelles. Smooth muscle contraction, clot retraction, beat of heart cells, and shortening of the tadpole tail are all cases in which no argument of substance for alternative causes can be offered. The morphogenetic processes in epithelia, contractile ring function during cytokinesis, migration of cells on a substratum, and streaming in plant cells can be explained most simply on the basis of contractility being the causal event in each process. The many similarities between the latter cases and the former ones in which contraction is certain argue for that conclusion. For instance, platelets probably contract, possess a microfilament network, and behave like undulating membrane organelles. Migrating cells possess undulating membranes and contain a similar network. It is very likely, therefore, that their network is also contractile. In all of the cases that have been examined so far, microfilaments of some type are observed in the cells; furthermore, those filaments are at points where contractility could cause the respective phenomenon. The correlations from the cytochalasin experiments greatly strengthen the case; microfilaments are present in control and "recovered" cells and respective biological phenomena take place in such cells; microfilaments are absent or altered in treated cells and the phenomena do not occur. The evidence seems overwhelming that microfilaments are the contractile machinery of nonmuscle cells. The argument is further strengthened if we reconsider the list of processes insensitive to cytochalasin (Table 2). Microtubules and their sidearms, plasma membrane, or synthetic machinery of cells are presumed to be responsible for such processes, and colchicine, membrane-active drugs, or inhibitors of protein synthesis are effective at inhibiting the respective phenomena. These chemical agents would not necessarily be expected to affect contractile apparatuses over short periods of time, they either do not or only secondarily interfere with the processes sensitive to cytochalasin (Table 1). It is particularly noteworthy in this context that microtubules are classed as being insensitive to cytochalasin and so are not considered as members of the "contractile microfilament" family. The overall conclusion is that a broad spectrum of cellular and developmental processes are caused by contractile apparatuses that have at least the common feature of being sensitive to cytochalasin. Schroeder's important insight (3) has, then, led to the use of cytochalasin as a diagnostic tool for such contracile activity: the prediction is that sensitivity to the drug implies presence of some type of contractile microfilament system. Only further work will define the limits of confidence to be placed upon such diagnoses. The basis of contraction in microfilament systems is still hypothetical. Contraction of glycerol-extracted cells in response to adenosine triphosphate (53), extraction of actin-like or actomyosin-like proteins from cells other than muscle cells (54), and identification of activity resembling that of the actomyosin-adenosine triphosphatase system in a variety of nonmuscle tissues (40, 54) are consistent with the idea that portions of the complex, striated muscle contractile system may be present in more primitive contractile machinery. In the case of the egg cortex, calcium-activated contractions can be inhibited by cytochalasin. If, as seems likely, microfilaments are the agents activated by calcium, then it will be clear that they have the same calcium requirement as muscle. Biochemical analyses of primitive contractile systems are difficult to interpret. Ishikawa's important observation (31), that heavy meromyosin complexes with fine filaments oriented parallel to the surface of chondrocytes and perpendicular to the surface of intestinal epithelial cells, implies that both types of filaments are "actin-like" in this one respect. Yet, it is very likely that these actin-like filaments correspond respectively to the cytochalasin-insensitive sheath of glial and heart fibroblasts and the core filaments of oviduct microvilli. No evidence from our studies links contractility directly to these meromyosin-binding filaments. Apart from this problem, activity resembling that of the myosin-adenosine triphosphatase has been associated with the microtubule systems of sperm tails and cilia (55), but those organelles are insensitive to cytochalasin in structure and function. Clearly, a means must be found to distinguish between enzymatic activities associated with microfilament networks, microfilament bundles, microtubules, and the sheath filaments of migratory cells. Until such distinctions are possible, little of substance can be said about the molecular bases of primitive contractile systems. Three variables are important for the control of cellular processes dependent upon microfilaments: (i) which cells of a population shall manufacture and assemble the filaments; (ii) where filaments shall be assembled in cells; and (iii) when contractility shall occur. With respect to distribution among cells, the networks involved in cell locomotion are presumed to be present in all cells that have the potential to move in cell culture. In this respect, the networks can be regarded as a common cellular organelle in the sense that cytoplasmic microtubules are so regarded. In some developing systems, all cells of an epithelium possess microfilament bundles (7, 13), whereas, in others, only discrete subpopulations possess the bundles (5, 6). In these cases the filaments can be regarded as being differentiation products associated only with certain cell types. These considerations may be related to the fact that microfilament networks are associated with behavior of individual cells (such as migration, wound healing, and cytokinesis), whereas the bundles are present in cells that participate in coordinated changes in shape of cell populations. With respect to placement in cells, two alternatives are apparent, namely, localized or ubiquitous association with the plasma membrane. Microfilament bundles of epithelial cells are only found extending across the luminal and basal ends of cells. In this respect they contrast with desmosomal tonofilaments and with microtubules, each of which can curve in a variety of directions through the cell. The strict localization of microfilament bundles probably rests upon their association with special junctional complex insertion regions that are only located near the ends of cells. In the case of mitotically active cells, the orientation of the spindle apparatus may determine the site at which the contractile ring of microfilaments will form (4, 56); this raises the question of what sorts of cytoplasmic factors can influence the process of association between filament systems and plasma membranes. In contrast to such cases of localized distribution, contractile networks responsible for cell locomotion are probably found beneath all of the plasma membrane, just as the network of thrombosthenin may extend to all portions of the periphery of a blood platelet. This ubiquitous distribution probably accounts for the ability of a fibroblast or glial cell to establish an undulating membrane at any point on its edge, or of an axon to form lateral microspikes along its length. The third crucial aspect of control of these contractile apparatuses involves the choice of when contraction shall occur (and as a corollary the degree or strength of contraction that will occur). In the simplest situation, contraction would follow automatically upon assembly of the microfilament bundles or networks. In cleavage furrows of marine embryos (4), for instance, microfilaments are seen beneath the central cleavage furrow and at its ends, but not beyond, under the portion of plasma membrane that will subsequently become part of the furrow. This implies that the furrow forms very soon after the contractile filaments are assembled in the egg cortex. In other cases, microfilaments are apparently assembled but not in a state of (maximal?) contraction. Thus, networks are seen along the sides of migratory cells, although such regions are not then active as undulating membrane organelles. Similarly, microfilament bundles occur in all epithelial cells of the salivary gland (13), or pancreatic anlage (7), although only the ones at discrete points are thought to generate morphogenetic tissue movements. Likewise, bundles begin to appear as early as 12 hours after estrogen administration to oviduct, although visible tubular gland formation does not start until 24 to 30 hours. Finally, streaming in plant cells can wax and wane, depending upon external factors such as auxin (57). All of these cases imply a control mechanism other than mere assembly of the microfilament systems and even raise the possibility that within one cell some filaments may be contracting while others are not. In discussing this problem, it must be emphasized that different degrees of contraction or relaxation cannot as yet be recognized with the electron microscope. In fact, every one of the cases cited above could be explained by contraction following immediately upon some subtle sort of "assembly." Inclusive in the latter term are relations between individual filaments, relations of the filaments and their insertion points on plasma membrane, and quantitative alterations in filament systems. Furthermore, the critical role of calcium and high-energy compounds in muscle contraction suggest that equivalent factors may be part of primitive, cytochalasinsensitive systems. The finding that calcium-induced contraction in the cortex of eggs is sensitive to cytochalasin strengthens that supposition and emphasizes the importance of compartmentalization of cofactors as a means of controlling microfilaments in cells.
在我们看来,所有受细胞松弛素抑制的现象都可被认为是由细胞器的收缩活动所致。平滑肌收缩、血块回缩、心脏细胞搏动以及蝌蚪尾巴缩短,在这些情况中,找不到关于其他替代原因的实质性依据。上皮细胞中的形态发生过程、胞质分裂期间收缩环的功能、细胞在基质上的迁移以及植物细胞中的原生质流动,若将收缩性视为每个过程的因果事件,就能得到最简洁的解释。后几种情况与前几种明确存在收缩的情况有诸多相似之处,这支持了上述结论。例如,血小板可能会收缩,拥有微丝网络,并且表现得像起伏的膜细胞器。迁移的细胞具有起伏的膜并包含类似的网络。因此,很有可能它们的网络也是可收缩的。在目前已研究的所有情况中,细胞内都观察到了某种类型的微丝;此外,这些微丝所处的位置正是收缩性可能引发相应现象的地方。细胞松弛素实验的相关性极大地强化了这一观点;对照细胞和“恢复”细胞中存在微丝,相应的生物学现象也在这些细胞中发生;处理过的细胞中微丝缺失或改变,相应现象也未出现。有压倒性的证据表明微丝是非肌肉细胞的收缩机制。如果我们重新审视对细胞松弛素不敏感的过程列表(表2),这一观点会得到进一步强化。微管及其侧臂、质膜或细胞的合成机制被认为是这些过程的负责者,秋水仙素、膜活性药物或蛋白质合成抑制剂能有效抑制相应现象。这些化学试剂在短时间内不一定会影响收缩装置,它们要么不会,要么只是间接干扰对细胞松弛素敏感的过程(表1)。在这种情况下,特别值得注意的是,微管被归类为对细胞松弛素不敏感,因此不被视为“收缩性微丝”家族的成员。总体结论是,广泛的细胞和发育过程是由收缩装置引起的,这些装置至少有一个共同特征,即对细胞松弛素敏感。施罗德的重要见解(3)促使人们将细胞松弛素用作这种收缩活动的诊断工具:预测是对该药物敏感意味着存在某种类型的收缩性微丝系统。只有进一步的研究才能确定对这种诊断的置信限度。微丝系统收缩的基础仍然是假设性的。甘油提取细胞对三磷酸腺苷(53)的收缩反应、从肌肉细胞以外的细胞中提取肌动蛋白样或肌动球蛋白样蛋白质(54),以及在多种非肌肉组织中鉴定出类似于肌动球蛋白 - 三磷酸腺苷酶系统的活性(40, 54),都与这样一种观点一致,即复杂的横纹肌收缩系统的某些部分可能存在于更原始的收缩机制中。就卵皮质而言,细胞松弛素可抑制钙激活的收缩。如果微丝很可能是被钙激活的因子,那么很明显它们与肌肉具有相同的钙需求。对原始收缩系统的生化分析很难解释。石川的重要观察结果(31)表明,重酶解肌球蛋白与平行于软骨细胞表面且垂直于肠上皮细胞表面排列的细丝结合,这意味着在这一方面这两种类型的细丝都是“肌动蛋白样”的。然而,很有可能这些肌动蛋白样细丝分别对应于神经胶质和心脏成纤维细胞对细胞松弛素不敏感的鞘以及输卵管微绒毛的核心细丝。我们的研究中没有证据将收缩性直接与这些重酶解肌球蛋白结合细丝联系起来。除了这个问题,类似于肌球蛋白 - 三磷酸腺苷酶的活性已与精子尾部和纤毛的微管系统相关联(55),但这些细胞器在结构和功能上对细胞松弛素不敏感。显然,必须找到一种方法来区分与微丝网络、微丝束、微管以及迁移细胞的鞘细丝相关的酶活性。在能够进行这种区分之前,关于原始收缩系统的分子基础几乎无法给出实质性的内容。对于依赖微丝的细胞过程的控制,有三个变量很重要:(i)群体中的哪些细胞将制造和组装细丝;(ii)细丝将在细胞的何处组装;(iii)收缩何时发生。关于在细胞间的分布,参与细胞运动的网络被认为存在于所有在细胞培养中具有移动潜力的细胞中。在这方面,就如同将细胞质微管视为一种常见的细胞器一样,这些网络也可被视为一种常见的细胞器。在一些发育系统中,上皮组织的所有细胞都拥有微丝束(7, 13),而在其他系统中,只有离散的亚群拥有这些微丝束(5, 6)。在这些情况下,细丝可被视为仅与某些细胞类型相关的分化产物。这些考虑可能与以下事实有关,即微丝网络与单个细胞的行为(如迁移、伤口愈合和胞质分裂)相关,而微丝束存在于参与细胞群体形状协调变化的细胞中。关于在细胞内的定位,有两种明显的选择,即与质膜局部或普遍关联。上皮细胞的微丝束仅在细胞的腔面和基端延伸。在这方面,它们与桥粒张力细丝和微管形成对比,后两者可以在细胞内沿各种方向弯曲。微丝束的严格定位可能取决于它们与仅位于细胞末端附近的特殊连接复合体插入区域的关联。在有丝分裂活跃的细胞中,纺锤体装置的方向可能决定微丝收缩环形成的位置(4, 56);这就引出了一个问题,即哪些细胞质因子可以影响细丝系统与质膜之间的关联过程。与这种局部分布的情况相反,负责细胞运动的收缩网络可能存在于整个质膜下方,就如同血栓收缩蛋白网络可能延伸到血小板周边的所有部分一样。这种普遍分布可能解释了成纤维细胞或神经胶质细胞在其边缘的任何点建立起伏膜的能力,或者轴突沿其长度形成侧向微刺的能力。这些收缩装置控制的第三个关键方面涉及收缩何时发生的选择(以及作为必然结果的收缩程度或强度)。在最简单的情况下,收缩会在微丝束或网络组装后自动发生。例如,在海洋胚胎的卵裂沟中(4),在中央卵裂沟及其末端下方可见微丝,但在随后将成为沟一部分的质膜部分之外则没有。这意味着在卵皮质中收缩细丝组装后不久沟就形成了。在其他情况下,微丝显然已经组装,但并非处于(最大?)收缩状态。因此,在迁移细胞的侧面可以看到网络,尽管这些区域当时并不是作为起伏的膜细胞器活跃。同样,微丝束存在于唾液腺(13)或胰腺原基(7)的所有上皮细胞中,尽管只有离散点的微丝束被认为会产生形态发生组织运动。同样,在给输卵管注射雌激素后12小时微丝束就开始出现,尽管直到24至30小时才开始出现可见的管状腺体形成。最后,植物细胞中的原生质流动会根据生长素等外部因素增强或减弱(57)。所有这些情况都意味着存在一种除了微丝系统简单组装之外的控制机制,甚至提出了在一个细胞内一些细丝可能在收缩而另一些细丝不收缩的可能性。在讨论这个问题时,必须强调的是,用电子显微镜还无法识别不同程度的收缩或松弛。事实上,上述每个例子都可以通过某种微妙的“组装”后立即收缩来解释。后一个术语包括单个细丝之间的关系、细丝与其在质膜上的插入点的关系以及细丝系统的定量变化。此外,钙和高能化合物在肌肉收缩中的关键作用表明,等效因素可能是原始的、对细胞松弛素敏感的系统的一部分。卵皮质中钙诱导的收缩对细胞松弛素敏感这一发现强化了这一假设,并强调了辅因子区室化作为控制细胞内微丝的一种手段的重要性。